In his new role, Mr. Hess will be managing, developing and maintaining the pipeline for InVivo’s entire product line. He will also lead the transition of InVivo’s technologies from research and development into clinical trials and production manufacturing.
During his time with Stryker, Mr. Hess led development teams through the FDA clearance process and won multiple awards for his work.
Related Articles on Orthopedic Devices:
Medtronic’s Biologics Business Down 20% in 3Q With Infuse Sales Dropping
Arthrex Launches Compact Video Imaging System
ArthroCare Revenues Down in 2011
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
